The Role of Artificial Intelligence in Reducing Drug Costs

Artificial Intelligence (AI) is reshaping the pharmaceutical industry by driving efficiency and reducing drug costs. AI's impact on drug development, clinical trials, and supply chain optimization accelerates processes, leading to substantial cost savings. VeriSIM Life and Generative AI contribute to forecasting clinical success, expediting drug discovery, and unveiling therapeutic possibilities. The cultural shift towards AI in pharma emphasizes its role in identifying failures earlier, streamlining R&D processes, and cutting development time and costs significantly. Beyond drug development, AI enhances diagnostics, personalizes patient care, and has the potential to lower overall healthcare costs. While challenges exist, the pharmaceutical industry anticipates increased AI investments, ensuring a more efficient and cost-effective healthcare future.